Reimbursement strategy

As a suite to my post entitled reimbursement intelligence of Saturday, here is a post talking about reimbursement strategy and payer marketing. According to a healthcare marketing consultant if facing a payer problem the principles are:

1) find a Key opinion Leader (KOL) other name: a thought leader in the disease area of your product

2) engage and have practitioners who participe to comparative effectivenes studies for your product

3) publish and broadcast the results

4) help hospital to become a center of excellence in the disease area of your product

5) establish disease management algorithms

6) invite the payer in a meeting at the hospital (4) with the KOL (1) to present him results of the studies (3) and treatment algorithms (5)

Reimbursement Intelligence

I wonder if such private societies exist in France?  I found two societies: “Reimbursement Intelligence” and “RADical Group” both of them presided by Rhonda Greenapple that advises biotech firms on how to gain and maximize reimbursement by health authorities (FDA) for innovative products in health care.

Reimbursement intelligence assisted a NASDAQ  enterprise named Repros Therapeutics Inc.® in reimbursement procedures near FDA for its innovative oral treatment for secondary hypogonadism in men: Androxal®.

In november 2010 the biotech firm didn’t obtained the phase 3 authorization from the FDA and this delay had at this time some consequence over the value of its stock exchanges actions.

If such consultants in reimbursement exist in France let me know.